This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Gains on Strong 4Q Results, 2019 Looks Favorable
by Zacks Equity Research
UnitedHealth (UNH) shares gained following a strong fourth-quarter results, operating fundamentals point to a solid 2019
The Zacks Analyst Blog Highlights: Intuitive Surgical, Illumina, HCA, Elanco Animal and Humana
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Intuitive Surgical, Illumina, HCA, Elanco Animal and Humana
Has HCA Healthcare (HCA) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (HCA) Outperforming Other Medical Stocks This Year?
HCA Holdings (HCA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
HCA Holdings (HCA) closed the most recent trading day at $131.49, moving +1.73% from the previous trading session.
UnitedHealth (UNH) Beats on 4Q Earnings, Keeps 2019 Guidance
by Zacks Equity Research
UnitedHealth's (UNH) fourth-quarter results gain from higher revenues and membership.
5 Great Medical Stocks to Buy Ahead of Q4 Earnings
by Swarup Gupta
A Reuters review of Wall Street Research firms reveals that health care is the most favored of the S&P 500's 11 major sectors.
First Full Week of 2019 Brings a Recovery Rally
by David Borun
Low interest rates and renewed China trade talks help stock keep the 2019 rally going.
What's in the Cards for UnitedHealth (UNH) Q4 Earnings?
by Zacks Equity Research
UnitedHealth's (UNH) Q4 performance should benefit from robust segmental revenues along with membership growth.
Is HCA Holdings (HCA) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured expert Kevin Matras highlights: BJ's Restaurants, O'Reilly Automotive, Amedisys, HCA Healthcare and Toyota Motor
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: BJ's Restaurants, O'Reilly Automotive, Amedisys, HCA Healthcare and Toyota Motor
HCA Holdings (HCA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, HCA Holdings (HCA) closed at $124.44, marking a +0.85% move from the previous day.
5 Sector ETFs & Stocks to Shine on Upbeat December Jobs Data
by Sanghamitra Saha
These sector ETFs and stocks should give solid performance in the coming days thanks to upbeat jobs data for the month of December.
Here Are 5 Stocks With Amazing Interest Coverage Ratio
by Zacks Equity Research
Interest Coverage Ratio is used to determine how effectively a company can pay the interest charged on its debt.
Why HCA (HCA) Could Beat Earnings Estimates Again
by Zacks Equity Research
HCA (HCA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Is HCA Healthcare (HCA) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (HCA) Outperforming Other Medical Stocks This Year?
Which Stock to Emulate HCA Healthcare (HCA) Success in 2019?
by Zacks Equity Research
While HCA Healthcare (HCA) has been a runaway winner this year, other companies by virtue of strong operating fundamentals are poised for growth in 2019.
3 Medical Stocks Likely to Emulate Illumina's Success in 2019
by Urmimala Biswas
Illumina's (ILMN) gains are indeed staggering. But is it the sole star in the firmament setting benchmarks for others to try and emulate?
Is HCA Holdings (HCA) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Top Stock Reports for Disney, U.S. Bancorp & EOG Resources
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Disney (DIS), U.S. Bancorp (USB) and EOG Resources (EOG).
Hospital Industry Outlook: High Cost, Shift of Care Pose Concerns
by Zacks Equity Research
The hospital industry should grow on increased demand from an aging population, rising incidence of disease and technological innovation amid shortage of labor and shift of care to a low-cost setting.
Healthcare ETFs Sink on JNJ News, ACA Ruling: What???s Ahead?
by Sweta Killa
Healthcare took a hit recently on Johnson & Johnson news and a federal judge ruling. The rough trading also spread into the ETF world.
Healthcare Battered By Texas ACA Ruling
by Zacks Equity Research
Healthcare Battered By Texas ACA Ruling
Healthcare Stocks Take a Hit on Texas ACA Ruling
by Mark Vickery
Throwing out ACA as healthcare law in the U.S. would create plenty of tremors within the healthcare industry -- to say nothing of Insurance, Pharmaceuticals and related business sectors.
The Zacks Analyst Blog Highlights: Intuitive Surgical, HCA Healthcare, Exelon, 3M and Micron
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Intuitive Surgical, HCA Healthcare, Exelon, 3M and Micron
Has HCA Healthcare (HCA) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (HCA) Outperforming Other Medical Stocks This Year?